Pembrolizumab 25 MG/ML [KEYTRUDA®]
Sponsors
Cytovation AS
Conditions
Advanced Breast CancerAdvanced Head and Neck Squamous Cell CarcinomaAdvanced MelanomaAdvanced Solid Tumor Malignancy
Phase 1
CyPep-1 Injections in Cancer Inducing Lymphocyte Infiltrate Accumulations
CompletedNCT04260529
Start: 2020-04-30End: 2024-07-05Updated: 2026-01-29
A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers
CompletedNCT05383170
Start: 2023-03-21End: 2024-09-23Updated: 2025-11-28